DM
Damodar Mahapatra
About Damodar Mahapatra
Data last updated:
Damodar Mahapatra has experience in corporate governance. Holds Director role. Currently with 2 companies, including Kom-Med Labrotories Private Limited and Ropius Biotics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kom-Med Labrotories Private Limited at ₹1.95 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Nov 2025 | 2016 | ₹1.95 Cr (FY 2024) | Active | |
| Director | 03 Aug 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Damodar Mahapatra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Damodar Mahapatra
Damodar Mahapatra has experience in corporate governance. Holds Director role. Currently with 2 companies, including Kom-Med Labrotories Private Limited and Ropius Biotics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kom-Med Labrotories Private Limited at ₹1.95 Cr (FY 2024).
Damodar Mahapatra is associated with 2 companies as Director, including Kom-Med Labrotories Private Limited (₹1.95 Cr), Ropius Biotics Private Limited.
Damodar Mahapatra has expertise in General Business.
Damodar Mahapatra has extensive experience in corporate governance.
By reported revenue, the largest current company of Damodar Mahapatra is Kom-Med Labrotories Private Limited, with revenue of ₹1.95 Cr (FY 2024).
Damodar Mahapatra currently holds positions at 2 companies: Kom-Med Labrotories Private Limited (₹1.95 Cr), Ropius Biotics Private Limited.